Encompass Health Corporation
EHC NYSEHealthcare ★★★★★Latest Earnings
Date
Aug 5, 2026
ET
EPS Est.
1.48
EPS Actual
1.55
Revenue Est.
$1.57B
Revenue Actual
$1.6B
Next Earnings Report
Date
Oct 28, 2026 · Wed
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
1.38
Revenue Est.
$1.6B
Company Overview
Encompass Health Corporation (ticker EHC) is listed on NYSE with a market cap of about $11.93B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), After-market, with consensus EPS of 1.38. In the last 15 reported quarters, EPS beat consensus estimates 15 times.
Actual EPS TrendRecently15Term · Feb 7, 2023 → Aug 5, 2026
Feb 7, 2023Range: 0.86 ~ 1.60Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | 1.48 | 1.55 | $1.57B | $1.6B |
| Apr 30, 2026 | -- | 1.51 | 1.60 | $1.57B | $1.59B |
| Feb 5, 2026 | -- | 1.29 | 1.46 | $1.54B | $1.54B |
| Oct 29, 2025 | -- | 1.19 | 1.23 | $1.48B | $1.48B |
| Aug 5, 2025 | -- | 1.23 | 1.40 | $1.43B | $1.46B |
| Apr 24, 2025 | -- | 1.19 | Above forecast↑1.37 | $1.43B | $1.46B |
| Feb 6, 2025 | -- | 1.05 | 1.17 | $1.38B | $1.41B |
| Oct 28, 2024 | -- | 0.94 | 1.03 | $1.38B | $1.35B |
| Aug 5, 2024 | -- | 1.01 | 1.11 | $1.3B | $1.3B |
| Apr 24, 2024 | -- | 0.94 | Above forecast↑1.12 | $1.31B | $1.32B |
| Feb 7, 2024 | -- | 0.82 | Above forecast↑0.95 | $1.24B | $1.25B |
| Oct 26, 2023 | -- | 0.77 | 0.86 | $1.19B | $1.21B |
| Aug 1, 2023 | -- | 0.75 | Above forecast↑0.95 | $1.16B | $1.19B |
| Apr 27, 2023 | -- | 0.70 | Above forecast↑0.88 | $1.16B | $1.16B |
| Feb 7, 2023 | -- | 0.83 | 0.88 | $1.12B | $1.14B |
Original Filings (SEC)
8-K2026-08-13 ↗
10-Q2026-08-07 ↗
8-K2026-08-05 ↗
8-K2026-06-01 ↗
8-K2026-05-15 ↗
8-K2026-05-11 ↗
10-Q2026-05-01 ↗
8-K2026-04-30 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
